DocSym
β
Searchsearch
Search
(P54.5) Neonatal cutaneous haemorrhage
More details coming soon
277 162 in individuals diagnosis neonatal cutaneous haemorrhage confirmed
1 522 deaths with diagnosis neonatal cutaneous haemorrhage
1% mortality rate associated with the disease neonatal cutaneous haemorrhage
Diagnosis neonatal cutaneous haemorrhage is diagnosed Men are 14.69% more likely than Women
158 936
Men receive the diagnosis neonatal cutaneous haemorrhage
898 (0.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
118 226
Women receive the diagnosis neonatal cutaneous haemorrhage
624 (0.5 %)Died from this diagnosis.
Risk Group for the Disease neonatal cutaneous haemorrhage - Men and Women aged 0
In Men diagnosis is most often set at age 0-1
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-95+
In Women diagnosis is most often set at age 0-1
Disease Features neonatal cutaneous haemorrhage
Absence or low individual and public risk
Neonatal cutaneous haemorrhage - what does this mean
Neonatal cutaneous haemorrhage is a condition in which bleeding occurs in the skin of newborns, usually due to an underlying medical condition such as thrombocytopenia or von willebrand disease. it can also be caused by trauma during delivery or due to a congenital defect in the blood clotting system.
What happens during the disease - neonatal cutaneous haemorrhage
Neonatal cutaneous haemorrhage is caused by a combination of factors, including a lack of platelets in the blood, a decrease in the activity of clotting factors, and a decrease in the activity of the fibrinolytic system. in addition, the immature vascular system of newborns may be more prone to bleeding due to increased fragility of the capillary walls. this can lead to bleeding into the skin and other organs, resulting in the clinical signs of neonatal cutaneous haemorrhage.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination of the newborn
- Laboratory tests including complete blood count, clotting studies, and platelet count
- Ultrasound of the head and abdomen
- CT scan or MRI of the head and abdomen
- Skin biopsy
- Echocardiogram
- Genetic testing
Treatment and Medical Assistance
Main Goal: To reduce the risk of bleeding and manage any potential complications.
- Monitor the infant's vital signs regularly
- Provide adequate nutrition and hydration
- Administer medications to reduce the risk of bleeding
- Provide supportive care, such as oxygen and fluids
- Monitor for any signs of infection
- Observe for any changes in skin color
- Perform regular laboratory tests to monitor for any changes in blood clotting factors
- Provide regular physical therapy and rehabilitation
- Provide emotional support for the infant and family
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Neonatal cutaneous haemorrhage - Prevention
Neonatal cutaneous haemorrhage can be prevented by avoiding certain risk factors such as smoking during pregnancy, high blood pressure, and certain medications. additionally, proper prenatal care and regular monitoring of the baby's health can help to identify any potential issues early on.